comparemela.com

Latest Breaking News On - Deurali janta pharmaceuticals - Page 1 : comparemela.com

Phase-III trial of favipiravir starts in Kathmandu and Pokhara

news Phase-III trial of favipiravir starts in Kathmandu and Pokhara Kathmandu Post Kathmandu, Dec. 10 Nepal Health Research Council has decided to test antiviral medicine favipiravir on Covid-19 patients admitted to hospitals in Kathmandu and Pokhara. The drug, which is being administered under a phase-III trial, will be given to 600 patients with mild or moderate symptoms of the contagious disease. Yes the trial has started in Kathmandu and in Pokhara, a doctor involved in the study, told the post, asking not to be named, Favipiravir, originally made to treat flu in Japan, is being manufactured by Deurali-Janta Pharmaceuticals Pvt. Ltd in Nepal.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.